Big AI models will be commoditized — the value will come from the applications, Infosys chair says

Big AI models will be commoditized — the value will come from the applications, Infosys chair says


Infosys chair on the AI boom and the future of jobs

Massive artificial intelligence models built by the likes of OpenAI will eventually become commoditized with the next wave of value in the technology coming from the applications that are built on top of the models, the co-founder and chair of Infosys told CNBC on Tuesday.

Large language models are the AI models trained on amounts of data and they underpin applications like ChatGPT. Companies such as OpenAI and Meta are among the biggest players in this space.

Nandan Nilekani, co-founder of Infosys, said there are going to be many different LLMs around the world.

“There are many companies now coming up which are building India-specific LLM solutions for Indian languages … so I think what’s going to happen is that because AI is finally dependent on the data it is  trained on, every part of the world which has unique data will be required to do something about training the models for that data,” Nilekani told CNBC’s “Squaw Box Europe” on Tuesday.

“Ultimately, the models will become more commoditized and the value will switch to the application layer and the whole stack.”

Applications can be built on top of LLMs, and according to Nilekani, the next wave of value from AI will derive from those applications and other related technologies.

Infosys is one of India’s biggest technology companies offering outsourcing and consultancy services.

Discussing trends in AI, Nilekani said that the integration of AI into businesses, also known as enterprise AI, “is a longer cycle than consumer AI.”

“Consumer AI you can get up a chatbot and start working. Enterprise AI requires firms to reinvent themselves internally. So it’s a longer haul, but definitely it’s a huge thing happening right now,” Nilekani said.



Source

Novo Nordisk to buy Akero for up to .2 billion for promising liver drug
World

Novo Nordisk to buy Akero for up to $5.2 billion for promising liver drug

A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024.  Tom Little | Reuters Novo Nordisk said on Thursday it would buy Akero Therapeutics for up to $5.2 billion to add its promising experimental liver disease drug, in the first major deal […]

Read More
Ferrari shares plunge 14% after carmaker updates guidance, halves EV sales target
World

Ferrari shares plunge 14% after carmaker updates guidance, halves EV sales target

A worker on the production line at the new Ferrari NV E-building factory in Maranello, Italy, on Friday, June 21, 2024. Bloomberg | Bloomberg | Getty Images Shares of Ferrari plunged more than 14% on Thursday after the luxury carmaker updated its full-year and 2030 guidance and scaled back its electrification ambitions. The Maranello, Italy-based […]

Read More
Orsted to cut 2,000 jobs as Trump’s offshore wind battle continues
World

Orsted to cut 2,000 jobs as Trump’s offshore wind battle continues

Picture taken on September 4, 2023 shows windmills at the Nysted Offshore Wind Farm constructed by Danish windpower giant Orsted in 2002-2003 in the Baltic Sea near Gedser in Denmark. Thomas Traasdahl | Afp | Getty Images Beleaguered wind farm operator Orsted announced Thursday that it intends to reduce its workforce by a quarter toward […]

Read More